USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro

Int J Mol Sci. 2019 Oct 24;20(21):5300. doi: 10.3390/ijms20215300.

Abstract

The ubiquitin-proteasome system is an essential regulator of several cellular pathways involving oncogenes. Deubiquitination negatively regulates target proteins or substrates linked to both hereditary and sporadic forms of cancer. The deubiquitinating enzyme ubiquitin-specific protease 14 (USP14) is associated with proteasomes where it trims the ubiquitin chain on the substrate. Here, we found that USP14 is highly expressed in patients with lung cancer. We also demonstrated that USP14 inhibitors (IU1-47 and siRNA-USP14) significantly decreased cell proliferation, migration, and invasion in lung cancer. Remarkably, we found that USP14 negatively regulates lung tumorigenesis not only through apoptosis but also through the autophagy pathway. Our findings suggest that USP14 plays a crucial role in lung tumorigenesis and that USP14 inhibitors are potent drugs in lung cancer treatment.

Keywords: autophagy; deubiquitinating enzyme; lung cancer; ubiquitin-specific protease 14.

MeSH terms

  • Autophagy / drug effects*
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cell Transformation, Neoplastic / drug effects
  • Humans
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology*
  • Pyrroles / pharmacology*
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Ubiquitin Thiolesterase / antagonists & inhibitors
  • Ubiquitin Thiolesterase / genetics
  • Ubiquitin Thiolesterase / metabolism*

Substances

  • IU1-47
  • Pyrroles
  • RNA, Small Interfering
  • USP14 protein, human
  • Ubiquitin Thiolesterase